Aug 01, 2024
1:12
For every 12 shares held, investors received 1. The price per share adjusted from $0.41 to $0.03.
The split itself did not change the total investment value.
Evoke Pharma, Inc. (EVOK) trades on the NASDAQ Capital Market in the Drug Manufacturers - Specialty & Generic industry.
Evoke Pharma, Inc. company overviewThe latest split shown was on August 1, 2024. It was a 1-for-12 reverse split, so shareholders received 1 share for every 12 they held.
This history records 2 reverse splits between May 23, 2022 and August 1, 2024.